Despite doubts about the benefits of colon cancer screening, sigmoidoscopy and fecal occult blood tests are now often performed by clinicians who must then deal with positive test results. The purpose of this literature review is to examine potential strategies for dealing with positive screening test...
OPDIVO®(nivolumab) is a prescription medicine used to treat adults and children 12 years of age and older with a type of colon or rectal cancer (colorectal cancer) that has spread to other parts of the body (metastatic), is microsatellite instability-high (MSI-H) or mismatch repair defici...
S448Ambulatory Safety Net Improves Colorectal Cancer Recall Following a Positive Non-invasive Colon Cancer Screening Testdoi:10.14309/01.ajg.0000951432.86024.abJoseph D. FeuersteinBeth Israel Deaconess Medical Center, Boston, MA;Matthew GermakBeth Israel Lahey Health, Needham, MA;Jason Nigrosh...
Women living with HIV (WLHIV) are at increased risk for human papillomavirus (HPV)-associated anal cancer. Given the “field effect” of HPV pathogenesis, some recommend that anal cancer screening should be limited to WLHIV with prior genital disease. This study aimed to characterize the relatio...
If a person is at risk of colon cancer, the test may need to be repeated every year. Positive result: FOBT is considered positive if blood is detected in the stool sample. An additional test such as a colonoscopy may be needed to locate the source and cause of the bleeding. FOBT is ...
there is no disease. A false positive result is an error, which means the result is not giving you the correct information. As an example of a false positive, suppose ablood testis designed to detectcolon cancer. The test results come back saying a person has colon cancer when he actually...
(FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-like cells. CD44+CD133+high-expressing and other populations of human DLD-1 colon cancer cells were separately isolated through fluorescence-activated cell sorting. The ...
216 individuals aged 50 to 75 years who completed a fecal immunochemical test to screen for colorectal cancer at a large integrated health care setting between 2007 and 2011, the authors evaluated whether a positive test was associated with a net change in outpatient primary care visit use within...
More information:Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test–Based Screening,Annals of Internal Medicine(2022).DOI: 10.7326/M22-0301 Developing Meaningful Health Care Quality Metrics: An Example From Colonoscopy and Adenoma Detection,Annals of...
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer Purpose:A phase I/II study was designed to determine the maximum-tolerated dose (MTD) of iodine 125-labeled monoclonal antibody A33 (125I-mAb A33), its lim... S Welt,AM Scott,CR Divgi,...